OptiChamber® Advantage Valved Holding Chamber

Please check with your local Respironics Representative to find out if this product is available for purchase in your country.

Photo

OptiChamber Advantage Valved Holding Chamber was designed to optimize delivery of metered dose inhaler (MDI) asthma medication. OptiChamber makes available more of the smaller medication particles — those that can reach deep into the peripheral airways — than the smaller (AeroChamber® 145 ml) valved holding chamber developed in the early 1980s.¹-² And, OptiChamber has been clinically demonstrated to provide rapid lung function improvement when compared to drug delivered via jet nebulizer and a large volume (Volumatic®, 750 ml) spacer³. Designed to optimize patient value and ease-of-use, OptiChamber's replaceable valve facilitates cleaning and provides longer trouble-free performance. In addition, detachable masks adapt to changing patient needs and help keep costs to a minimum.


References:

  1. Dalby RN, et al. Evaluation of aerosol drug output from the OptiChamberand AeroChamber spacers in a model system. J Asthma 1998:35(2);1998.

  2. Beihn R, Doherty D. Comparative respiratory deposition of 99mTc labeled particles of albuterol using a metered dose inhaler, a metered dose inhaler with AeroChamber spacer and OptiChamber spacer in healthy volunteers using gamma-scintigraphy. Scintiprox, Inc., IN, and University of Kentucky Medical Center, KY, 1997 (Data on file, Respironics HealthScan Asthma & Allergy Products).

  3. Gibson PG, Wlodarczyk JH, Borgas T. Drug delivery in asthma: A comparison of spacers with jet nubuliser. Aust NZ J Med 1995:25,324-329. AeroChamber is a registered trademark of Monaghan Medical, Plattsburgh, NY. Volumatic is a registered trademark of Allen & Hanburys Ltd., Greenford, England.